论文部分内容阅读
目的探讨蝮蛇抗检酶，钙通道拮抗剂治疗急性脑梗塞不同病期的临床疗效。方法采用经头颅CT证实的脑梗塞患者45例，应用蝮蛇抗栓酶、尼莫地平治疗，按不同病期分组，进行疗效比较。结果超早期4例，基本治愈3例，进步回例。早期（急性期）13例，基本治愈8例，显著进步5例。恢复期28例，基本治愈9例，显著进步16例，进步2例，无变化1例。经统计学处理，超早期与早期组，基本治愈率无显著差异（P＞0．05）；超早期、早期组与恢复期组基本治愈率有显著差异（P＜0．05）。结论蝮蛇抗栓酶、尼莫地平联合治疗超早期、早期（急性期）脑梗塞效果较显著。
Objective To investigate the clinical efficacy of Viper anti-test enzyme and calcium channel antagonist in the treatment of acute cerebral infarction at different stages. Methods Fifty-five patients with cerebral infarction confirmed by skull CT were treated with viper snake antithrombin and nimodipine, and were compared according to different stages. Results of ultra-early 4 cases, basically cured in 3 cases, improve the case back. Early (acute phase) in 13 cases, the basic cure in 8 cases, a significant improvement in 5 cases. Recovery of 28 cases, 9 cases of basic cure, a significant improvement in 16 cases, 2 cases improved, no change in 1 case. There was no significant difference (P> 0.05) between the early treatment group and the early treatment group, and the difference between the early treatment group and the recovery treatment group was significant (P <0.05). Conclusion Virifasin antithrombin, nimodipine combined treatment of ultra-early, early (acute) cerebral infarction effect is more significant.